Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Early research (Phase 1)Study completedNCT05091073
What this trial is testing

A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants

Who this might be right for
Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD RiskElevated CholesterolHealthy Volunteers
Novo Nordisk A/S 73
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013
What this trial is testing

Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company 17,300